These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18860241)

  • 1. Experimental therapy of onchocerciasis with trivalent antimonials.
    BARTTER FC; BURCH TA
    Ann N Y Acad Sci; 1948 May; 50(21-26):89-96. PubMed ID: 18860241
    [No Abstract]   [Full Text] [Related]  

  • 2. [2 Cases showing the therapeutic results in onchocerciasis after treatment with mel W (pentylthioarsaphenylmelamine) and TWSb (antimony dimercaptosuccinate)].
    FRIEDHEIM EA; de JONGH R
    Bull Soc Pathol Exot Filiales; 1960; 53():43-6. PubMed ID: 13825071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Robles' disease (onchocercosis). Therapeutic trials of astiban].
    AGUILAR FJ; BERNHARD JA
    Salud Publica Mex; 1962; 4():219-24. PubMed ID: 13859682
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of therapeutic values of several antimonials in experimental schistosomiasis mansoni in mice.
    SCHUBERT M; GOLDBERG E
    Fed Proc; 1948 Mar; 7(1 Pt 1):254. PubMed ID: 18861296
    [No Abstract]   [Full Text] [Related]  

  • 5. [EXPERIMENTAL THERAPY OF SCHISTOSOMIASIS JAPONICA. XIII. FURTHER STUDIES ON THE ENHANCEMENT OF SCHISTOSOMACIDAL ACTIVITY OF ANTIMONIALS BY GLYCERIN IN THE TREATMENT OF EXPERIMENTAL SCHISTOSOMIASIS].
    SHIAO SH; SHAO BR; LOH WC; CIE YR; WANG KF
    Yao Xue Xue Bao; 1962 Mar; 9():155-61. PubMed ID: 14073960
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental therapy of onchocerciasis with sumarin and hetrazan.
    BURCH TA
    Bol Oficina Sanit Panam; 1949 Mar; 28(3):233-48. PubMed ID: 18115779
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental therapy of onchocerciasis with suramin and hetrazan; results of a three-year study.
    BURCH TA; ASHBURN LL
    Am J Trop Med Hyg; 1951 Sep; 31(5):617-23. PubMed ID: 14878108
    [No Abstract]   [Full Text] [Related]  

  • 8. The determination of antitrypanosome effect of antimonials in vitro.
    CHEN G; GEILING EM
    J Infect Dis; 1945; 77():139-43. PubMed ID: 21003563
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic and toxic properties of oxygen versus sulfur bound trivalent antimony in organic antimonials.
    LUTTERMOSER GW; HASKINS WT; BRADY FJ
    J Pharmacol Exp Ther; 1949 Nov; 97(3):276-82. PubMed ID: 15406742
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood levels and excretion rates of antimony in persons receiving trivalent and pentavalent antimonials.
    OTTO GF; MAREN TH; BROWN HW
    Am J Hyg; 1947 Sep; 46(2):193-211. PubMed ID: 20262045
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON MECHANISMS OF ACTION OF CERTAIN ANTIDOTES AGAINST TRIVALENT ANTIMONIALS AND ON THE FATE OF ANTIMONY IN THE BLOOD].
    LOH CL; CIE YR
    Yao Xue Xue Bao; 1965 Feb; 12():92-101. PubMed ID: 14295459
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimony compounds in tuberculosis; their effect on experimental tuberculosis in guinea pigs.
    ROSE HM; GELLHORN A; CULBERTSON JT
    Am Rev Tuberc; 1946 Sep; 54(3):299-304. PubMed ID: 20274638
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimony in the treatment of leprosy.
    DAVISON AR
    Int J Lepr; 1948; 16(1):. PubMed ID: 18912633
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni.
    BUEDING E; MANSOUR JM
    Br J Pharmacol Chemother; 1957 Jun; 12(2):159-65. PubMed ID: 13446367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between distribution of antimony in tissues and chemotherapeutic effect in experimental leishmaniasis.
    GELLHORN A; VAN DYKE HB
    J Pharmacol Exp Ther; 1946 Oct; 88(2):162-72. PubMed ID: 20274538
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
    Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of schistosomiasis mansoni by antimony dimercaptosuccinate (TWSb). Comparison with tartar emetic].
    PRATA A
    Hospital (Rio J); 1961 Dec; 60():933-45. PubMed ID: 14488514
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressive management of schistosomiasis with antimony dimercaptosuccinate.
    DAVIS A
    Ann Trop Med Parasitol; 1961 Jul; 55():256-61. PubMed ID: 13720137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrocardiographic alterations caused by trivalent antimonials in the treatment of patients with schistosomiasis].
    TEIXEIRA R; PRATA A
    Hospital (Rio J); 1960 Nov; 58():915-9. PubMed ID: 13775752
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the distribution and fate of antimony when used as tartar emetic and fuadin in the treatment of American soldiers with schistosomiasis japonica.
    LIPPINCOTT SW; ELLERBROOK LD
    J Clin Invest; 1947 May; 26(3):370-8. PubMed ID: 20257799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.